Rasionalitas Regimen Dosis Gentamisin Pada Pasien Rawat Inap Di RSUP Dr. Kariadi Semarang (Kajian Terhadap Efektivitas Terapi Dan Peningkatan Serum Kreatinin)
Fita Rahmawati(1*), Arroyani Asa Dilaga(2), Djoko Wahyono(3)
(1) Universitas Gadjah Mada
(2) Universitas Gadjah Mada
(3) Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Gentamisin merupakan antibiotik pada terapi empiris khususnya infeksi bakteri gram negatif. Gentamisin memiliki indeks terapi sempit serta bersifat nefrotoksik. Pencegahan nefrotoksisitas dan peningkatan efektivitas terapi gentamisin dapat dilakukan dengan penyesuaikan regimen dosis berdasarkan nilai klirens kreatinin pasien. Penelitian bertujuan mengevaluasi rasionalitas dosis gentamisin serta mengetahui hubungan rasionalitas dosis dengan efektivitas terapi gentamisin dan efek peningkatan serum kreatinin.
Penelitian ini menggunakan rancangan cross sectional dilakukan di RSUP Kariadi Semarang. Sejumlah 129 rekam medis pasien rawat inap tahun 2018- 2019 dipilih menggunakan tehnik purpusive sampling. Kriteria inklusi meliputi usia pasien 18 tahun ke atas, menggunakan gentamisin injeksi minimal 3 hari, terdapat data serum kreatinin minimal sebanyak dua kali (sebelum dan sesudah penggunaan injeksi gentamisin). Efektivitas terapi terbagi menjadi membaik dan tidak membaik berdasarkan rekam medis pasien. Peningkatan serum kreatinin ditunjukkan dengan kenaikan sebesar 0,5 mg/dl atau lebih. Statistik bivariat Fisher exact test digunakan untuk mengetahui hubungan kedua variabel.
Hasil penelitian menunjukkan dosis rasional terdapat pada 19 (14,73% ) pasien dimana 15 (11,63%) pasien memberikan hasil terapi membaik dan terjadi peningkatan sCr lebih dari 0,5 mg/dl pada 5 (3,88 %) pasien. Sedangkan dosis tidak rasional terdapat pada 110 (85,27%) pasien dimana 52 (40,31%) pasien memberikan hasil terapi membaik dan 31 (24,03%) pasien terjadi peningkatan sCr. Rasionalitas regimen dosis memiliki hubungan signifikan dengan efektitivitas terapi (p<0,05) namun tidak memiliki hubungan signifikan dengan peningkatan serum kreatinin (p>0,05). Peran farmasis diperlukan dalam monitoring terapi pasien sehingga diharapkan dapat meningkatkan optimasi terapi dan menurunkan efek samping.
Keywords
Full Text:
PDFReferences
Alahdal, A.M. dan Elberry, A.A., 2012. Evaluation of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharmaceutical Journal, 20: 217–220. URL:http://www.sciencedirect.com/science/article/pii/S1319016411001162
Alldredge, B. K., Corelli, R. dan L., Ernts, M. E., Gugliemo, B. J., Jacobson, P. A. , Kradjan, W. A., D. (Editor), 2013. Applied Therapeutics: The Clinical Use of Drugs, 10th ed. Wolters Kluwer/Lippincort William & Wilkins, Philadelphia.
America, I.D.S. of, Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., dkk., 2007. Infectious Diseases Society of America / American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults 44: S27–72. URL: https://www.thoracic.org/statements/resources/tb-opi/idsaats-cap.pdf
APhA’s, 2015. Drugs Information Handbook, 24th ed. Lexicomp, United State.
Bauer, L.A., 2008. Applied Clinical Pharmacokinetics, 2nd ed. Mc Graw-Hill Medical, New York.
Dahlan, Sopiyudin M. 2013. Besar Sampel dan Cara Pengambilan Sampel. Jakarta: Salemba Medika
Dinh, T. dan Veves, A., 2008. The influence of gender as a risk factor in diabetic foot ulceration. Wounds: A Compendium of Clinical Research and Practice, 20: 127–131. URL: https://pubmed.ncbi.nlm.nih.gov/25942414/
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., dan Posey, L.M., 2017. Pharmacotherapy A Pathophysiologic Approach. Mc Graw-Hill Education Medical, New York.
Falagas, M.E., Mourtzoukou, E.G., dan Vardakas, K.Z., 2007. Sex differences in the incidence and severity of respiratory tract infections. Respiratory Medicine, 101: 1845–1863. URL:https://www.sciencedirect.com/science /article/pii/S0954611107001527
Finch, R.G., Greenwood, D., Norrby, S.R., dan Whitley, R.J., 2010. Antibiotic and Chemotheraphy, NINTH EDIT. ed. Saunders Elsevier, Edinburgh, London, New York, Philadelphia, St Louis Sydney Toronto.
Fleischmann, C., Scherag, A., Adhikari, N.K.J., Hartog, C.S., Tsaganos, T., Schlattmann, P., dkk., 2015. Assessment of Global Incidence and Mortality of Hospital-Treated Sepsis – Current Estimates and Limitations. 193(3):259-72. URL: https://pubmed.ncbi.nlm.nih.gov/26414292/
Humes, H.D., Harrinoton, J.T., dan Kassirer, J.P., 1988. Aminoglycoside nephrotoxicity. Kidney International, 33: 900–911. URL: https://core.ac.uk/download/pdf/82177291.pdf
Kalil, A.C., Metersky, M.L., Klompas, M., Muscedere, J., Sweeney, D.A., Palmer, L.B., dkk., 2016. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia : 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases®, 63: 61–111. URL: https://www.thoracic.org/statements/resources/tb-opi/hap-vap-guidelines-2016.pdf
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., dkk., 2017. Antimicrobial Activity and Resistance: Influencing Factors. Frontiers in Pharmacology, 8: 1–11. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468421/
Luna, C.M., Palma, I., Niederman, M.S., Membriani, E., Giovini, V., Wiemken, T.L., dkk., 2016. The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia. Annals of the American Thoracic Society, 13: 1519–1526. URL; https://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201512-848OC
Mahmoudi, L., Niknam, R., Mousavi, S., Ahmadi, A., Honarmand, H., Ziaie, S., dkk., 2013. Optimal Aminoglycoside Therapy Following the Sepsis : How Much Is Too Much ? Iranian Journal of Pharmaceutical Research (2013), 12: 261–269. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813230/
Naughton, C.A., 2008. Drug-Induced Nephrotoxicity. American Family Physician, 78, Number: 743–750. URL: https://www.aafp.org/afp/2008/0915/p743.html?utm_source=yahoo&utm_medium=referral&utm_campaign=in-text-link
Nicolle, L.E., 2005. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005, 16: 349–360. URL: https://pubmed.ncbi.nlm.nih.gov/18159518/
Paterson, D.L., Robson, J.M.B., dan Wagener, M.M., 1998, Risk factors for toxicity in elderly patients given aminoglycosides once daily. Journal of General Internal Medicine, 13: 735–739. URL: https:s//link.springer.com/article/10.1046/j.1525-1497.1998.00224.x
Paul E. Marik, MD, F., 2006. Management of the critically ill geriatric patient. Society of Critical Care Medicine and Lippincott Williams & Wilkins, 34: S176–S182. URL: https://journals.lww.com/ccmjournal/Abstract/2006/09001/Management_of_the_critically_ill_geriatric_patient.2.aspx
Pramono, Z.D., 2020, Evaluasi Kesesuaian Dosis dan Clinical Outcome Amikasin dan Gentamisin di NICU (Neonatal Intensive Care Unit) RSUP DR. Sardjito Yogyakarta, Magister Farmasi Klinik, Universitas Gadjah Mada, Yogyakarta.
Pratiwi, T.A., 2018. Evaluasi Pendosisan Aminoglikosida Terhadap Efektivitas Dan Fungsi Ginjal Pada Pasien Dengan Gangguan Ginjal Kronis . Universitas Gadjah Mada.
Simoens, S., 2011. Factors Affecting the Cost Effectiveness of Antibiotics. Chemotherapy Research and Practice, 2011: 1–6. URL: https://downloads.hindawi.com/archive/2011/249867.pdf
Tamma, P.D., Cosgrove, S.E., dan Maragakis, L.L., 2012. Combination Therapy for Treatment of Infections with Gram-Negative Bacteria. Clinical Microbiology Reviews, 25: 450–470. URL: https://journals.asm.org/doi/full/10.1128/CMR.05041-11
Tunger, O., Karakaya, Y., Cetin, C.B., Dinc, G., dan Borand, H., 2003. Rational antibiotic use. J Infect Developing Countries, 3: 88–93. URL: https://jidc.org/index.php/journal/article/view/54
Wahyono, D., 2013. Farmakokinetika Klinik : Konsep Dasardan Terapan Dalam Farmasi Klinik. Gadjah Mada University Press.
Wargo, K.A. dan Edwards, J.D., 2014, Aminoglycoside-Induced Nephrotoxicity. Journal of Pharmacy Practice, 27: 573–577. URL: https://pubmed.ncbi.nlm.nih.gov/25199523/
Weiskopf, D., Weinberger, B., dan Grubeck-loebenstein, B., 2009. The aging of the immune system 22: 1041–1050. URL: https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1432-2277.2009.00927.x
DOI: https://doi.org/10.22146/farmaseutik.v19i1.67189
Article Metrics
Abstract views : 1178 | views : 4477Refbacks
- There are currently no refbacks.